Zheng K, Zhu X, Fu S, Cao G, Li WQ, Xu L, Chen H, Wu D, Yang R, Wang K, Wang X*. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.,Radiology,2022:211545.

Hu J, Bao Q, Cao G, Zhu X, Yang R, Ji X, Xu L, Zheng K, Li W, Xing B, Wang X*. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.,Cardiovascular and interventional radiology,2020, 43(7):996-1005.

Zheng K, Fu S, Leng B, Cui Y, Yang R, Cao G, Xu L, Li W-Q, Li Y, Zhu X，Wang X*. Signal enhancement ratio of CE-MRI: a potential biomarker of survival after hepatic arterial infusion chemotherapy in biliary tract cancers.,Insights into Imaging,2022, 14;13(1):46.

Zheng K, Wang X*, Cao G, Xu L, Zhu X, Fu L, Fu S, Cheng H, Yang R: Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Gallbladder Cancer.,Cardiovascular and interventional radiology,2021 Feb;44(2):271-280.

Jungang Hu, Guang Cao, Liang Xu, Kanglian Zheng, Xu Zhu, Renjie Yang, Xiao Wang, Xiaodong Wang*. Retrograde embolization technique of the right gastric artery during the implantation of port-catheter system for hepatic arterial infusion chemotherapy.,Journal of Interventional Medicine,

郑康炼，王晓东* 胆道恶性肿瘤系统治疗与局部治疗的现状及进展,临床肝胆病杂志,2022.2:483-488

《原发性肝癌介入治疗》主编, 主编, 人民卫生出版社, 2019.9

“肝动脉持续灌注化疗在肝脏恶性肿瘤的临床应用”, 科技二等奖, 第3完成人, 中国抗癌协会, 2019.9

基于多模态影像组学和液态活检多组学的肝门胆管癌人工智能辅助HAIC 疗效预测和评效模型研究, 课题负责人, 2022.1.1～2025.12.31, 国家自然科学基金面上项目

重点培育专业：肝胆肿瘤微创介入学, 课题负责人, 2021.1.1～2023.12.30, 临床医学发展专项“扬帆”计划重点医学专业（重点培育专业）

“基于免疫微环境的冷冻消融对PD1免疫检查点抑制剂治疗肝癌的协同机制研究”, 课题负责人, 2021.1.1～2023.12.30, 北京市自然科学基金面上项目

基于CBCT的三维/四维可视化介入影像导航关键问题的研究, 课题负责人, 2015.1.1～2018.12.31, 国家自然科学基金面上项目课题81471759